Effect of a novel cognitive enhancer on decreased CaMKII activity in Schizophrenia model rats

被引：0
|
作者：
Yabuki, Y. [1 ]
Fukunaga, K. [1 ]
机构：
[1] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan
来源：
JOURNAL OF NEUROCHEMISTRY | 2015年 / 134卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
WTH11-19
引用
收藏
页码：320 / 320
页数：1
相关论文
共 50 条
  • [31] Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects
    Magdalena Białoń
    Marcelina Żarnowska
    Lucyna Antkiewicz-Michaluk
    Agnieszka Wąsik
    Psychopharmacology, 2020, 237 : 1577 - 1593
  • [32] CHRONIC TREATMENT WITH 1METIQ INDUCES PRO-COGNITIVE EFFECT ON RECOGNITION MEMORY IN KETAMINE MODEL OF SCHIZOPHRENIA IN RATS
    Bialon, Magdalena
    Wasik, Agnieszka
    Zarnowska, Marcelina
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S117 - S117
  • [33] Pro-cognitive effect of 1MeTIQ on recognition memory in the ketamine model of schizophrenia in rats: the behavioural and neurochemical effects
    Bialon, Magdalena
    Zarnowska, Marcelina
    Antkiewicz-Michaluk, Lucyna
    Wasik, Agnieszka
    PSYCHOPHARMACOLOGY, 2020, 237 (06) : 1577 - 1593
  • [34] DECREASED PLATELET MONO-AMINE OXIDASE ACTIVITY IN CHRONIC-SCHIZOPHRENIA, SHOWN WITH NOVEL SUBSTRATES
    BERRETTINI, WH
    PROZIALECK, W
    VOGEL, WH
    ARCHIVES OF GENERAL PSYCHIATRY, 1978, 35 (05) : 600 - 605
  • [35] Effect of Galectin-3 on the pathogenesis mechanism in the model of schizophrenia rats
    赵孟
    China Medical Abstracts(Internal Medicine), 2019, 36 (02) : 128 - 128
  • [36] Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia
    Alexandra I. Zugno
    Ricardo Filipe Julião
    Josiane Budni
    Ana Maria Volpato
    Daiane B. Fraga
    Felipe D. Pacheco
    Pedro F. Deroza
    Renata D. Luca
    Mariana B. de Oliveira
    Alexandra S. Heylmann
    João Quevedo
    Metabolic Brain Disease, 2013, 28 : 501 - 508
  • [37] Rivastigmine reverses cognitive deficit and acetylcholinesterase activity induced by ketamine in an animal model of schizophrenia
    Zugno, Alexandra I.
    Juliao, Ricardo Filipe
    Budni, Josiane
    Volpato, Ana Maria
    Fraga, Daiane B.
    Pacheco, Felipe D.
    Deroza, Pedro F.
    Luca, Renata D.
    de Oliveira, Mariana B.
    Heylmann, Alexandra S.
    Quevedo, Joao
    METABOLIC BRAIN DISEASE, 2013, 28 (03) : 501 - 508
  • [38] Vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic MK-801 model in rats
    Bozkurt, Nuh Mehmet
    Unal, Gokhan
    BEHAVIOURAL BRAIN RESEARCH, 2023, 444
  • [39] Cognitive deficits in rats exposed to methylazoxymethanol (MAM) on gestational day 17; A preclinical model of schizophrenia
    Flagstad, P
    Glenthoj, B
    Didriksen, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S435 - S436
  • [40] EFFECT OF A NEW COGNITIVE DRUG-ENHANCER S-12024-2 ON EEG SLEEP RECORDINGS IN RATS
    DESAINTHILAIRE, Z
    GAILLARD, JM
    SARBACH, SD
    GUEZ, D
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 52 (04) : 819 - 823
12345